PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling

被引:167
作者
Takahashi, Y
Morales, FC
Kreimann, EL
Georgescu, MM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
关键词
cancer; EBP50; NHERF; PDGFR; PTEN;
D O I
10.1038/sj.emboj.7600979
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PTEN, a tumor suppressor frequently inactivated in many human cancers, directly antagonizes the activity of phosphatidylinositol-3- OH kinase ( PI3K) by dephosphorylating phosphoinositides. We show here that PTEN interacts directly with the NHERF1 and NHERF2 ( Na (+)/ H (+) exchanger regulatory factor) homologous adaptor proteins through the PDZ motif of PTEN and the PDZ1 domain of NHERF1 or both PDZ domains of NHERF2. NHERFs were shown to interact directly with platelet- derived growth factor receptor ( PDGFR), and we demonstrate the assembly of a ternary complex between PTEN, NHERFs and PDGFR. The activation of the PI3K pathway after PDGFR stimulation was prolonged in NHERF1( -/ -) mouse embryonic fibroblasts as compared to wild- type cells, consistent with defective PTEN recruitment to PDGFR in the absence of NHERF1. Depletion of NHERF2 by small interfering RNA similarly increased PI3K signaling. Phenotypically, the loss of NHERF1 enhanced the PDGF-induced cytoskeletal rearrangements and chemotactic migration of the cells. These data indicate that, in normal cells, NHERF proteins recruit PTEN to PDGFR to restrict the activation of the PI3K.
引用
收藏
页码:910 / 920
页数:11
相关论文
共 39 条
[1]   Functional definition of relevant epitopes on the tumor suppressor PTEN protein [J].
Andrés-Pons, A ;
Valiente, M ;
Torres, J ;
Gil, A ;
Roglá, I ;
Ripoll, F ;
Cervera, J ;
Pulido, R .
CANCER LETTERS, 2005, 223 (02) :303-312
[2]   NHERF (Na+/H+ Exchanger Regulatory Factor) gene mutations in human breast cancer [J].
Dai, JL ;
Wang, L ;
Sahin, AA ;
Broemeling, LD ;
Schutte, M ;
Pan, Y .
ONCOGENE, 2004, 23 (53) :8681-8687
[3]   Membrane-binding and activation mechanism of PTEN [J].
Das, S ;
Dixon, JE ;
Cho, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7491-7496
[4]   Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF [J].
Demoulin, JB ;
Seo, JK ;
Ekman, S ;
Grapengiesser, E ;
Hellman, U ;
Rönnstrand, L ;
Heldin, CH .
BIOCHEMICAL JOURNAL, 2003, 376 :505-510
[5]   Crystal structures of a complexed and peptide-free membrane protein-binding domain: Molecular basis of peptide recognition by PDZ [J].
Doyle, DA ;
Lee, A ;
Lewis, J ;
Kim, E ;
Sheng, M ;
MacKinnon, R .
CELL, 1996, 85 (07) :1067-1076
[6]   Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions [J].
Fouassier, L ;
Yun, CC ;
Fitz, JG ;
Doctor, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) :25039-25045
[7]   The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region [J].
Georgescu, MM ;
Kirsch, KH ;
Akagi, T ;
Shishido, T ;
Hanafusa, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10182-10187
[8]  
Georgescu MM, 2000, CANCER RES, V60, P7033
[9]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316
[10]  
HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813